Skip to main content
Formycon AG logo

Formycon AG — Investor Relations & Filings

Ticker · FYB ISIN · DE000A1EWVY8 LEI · 39120005TZ76GQOY8Z19 F Manufacturing
Open in API
Filings indexed 363 across all filing types
Latest filing 2021-02-01 Annual Report
Country DE Germany
Listing F FYB

About Formycon AG

https://www.formycon.com/en/

Formycon AG is an independent, globally operating biopharmaceutical company specializing in the development of high-quality biosimilars. As a pure-play biosimilar developer, the company focuses on creating follow-on products for complex biopharmaceutical medicines after their patent protection has expired. The core mission is to enhance patient access to safe, effective, and affordable biologic therapies. Formycon's development activities are concentrated in therapeutic areas with high medical need, including ophthalmology and immunology. The company manages the entire development process, from analytics and process development to clinical trials and regulatory approval submissions for its biosimilar candidates.

Recent filings

Filing Released Lang Actions
Jahresabschluss zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
Annual Report Classification · 100% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) and 'Lagebericht' (Management Report) for Formycon AG for the fiscal year 2019. It contains detailed financial data, business model descriptions, and management analysis. According to the definitions, a comprehensive annual report covering company activity and financial performance is classified as a 10-K. FY 2019
2021-02-01 German
Formycon's Scientific Collaboration Partners present FYB207 Results at International Keystone Symposium
Regulatory Filings Classification · 100% confidence The document is a press release dated January 13, 2021, announcing that scientific partners are presenting results on Formycon's COVID-19 drug (FYB207) at an international symposium. It details scientific findings, mentions upcoming regulatory steps (Scientific Advice at Paul-Ehrlich-Institute), and includes standard corporate boilerplate and contact information. This is not a formal regulatory filing like a 10-K, an earnings release (ER), or a comprehensive interim report (IR). It is an announcement about scientific progress and publication, which fits best under the general category of corporate news or regulatory filings that don't fit elsewhere. Since it is a specific announcement about scientific/research progress rather than a financial report or management change, and it is disseminated via DGAP (a service for regulatory announcements and press releases), the most appropriate classification among the provided options is 'Regulatory Filings' (RNS) as a general corporate news announcement, or potentially 'IP' if it were an investor presentation, but here it is a press release about a scientific presentation. Given the context of scientific updates often being disseminated broadly, RNS serves as the best fit for a non-standard, non-financial regulatory/corporate news item.
2021-01-13 English
Formycon Reports on Virtual Annual General Meeting 2020
AGM Information Classification · 98% confidence The document is titled "Formycon Reports on Virtual Annual General Meeting 2020" and explicitly discusses the outcomes of the Annual General Meeting (AGM), including shareholder approvals, ratification of board actions, and election results for the Supervisory Board. This content directly aligns with the definition of AGM Information (AGM-R). Although it reports on the meeting, it is not merely an announcement of a future meeting (like a Proxy Statement, PSI) but a report on the completed event and its results, making AGM-R the most specific fit over a general Regulatory Filing (RNS). The length (7400 chars) suggests it is more than a brief announcement.
2020-12-14 English
Innovative SARS-CoV-2 Blocker from Formycon Completely Prevents Infection of Cells
Regulatory Filings Classification · 99% confidence The document is a press release dated December 9, 2020, announcing scientific publication results regarding Formycon's SARS-CoV-2 blocker (FYB207). It details scientific findings, mentions future plans for funding and strategic partnerships, and concludes with standard corporate boilerplate and contact information. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). Since it is a news announcement about scientific progress and corporate strategy updates, and it doesn't fit the specific categories like M&A (TAR), Capital (CAP), or Director's Dealing (DIRS), the most appropriate general category for a corporate news announcement that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a broad category for miscellaneous corporate news releases distributed via services like DGAP/EQS.
2020-12-09 English
Chief Operating Officer Dr. Stefan Glombitza appointed to Formycon AG's Management Board for another Four Years
Board/Management Information Classification · 100% confidence The document is a press release announcing a personnel change: the reappointment of the Chief Operating Officer (COO) for another four years. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2020-11-24 English
Formycon Reports its Nine-month Figures for 2020
Earnings Release Classification · 100% confidence The document is titled "Formycon Reports its Nine-month Figures for 2020" and explicitly details financial results for the first nine months of the fiscal year 2020 (e.g., turnover, EBITDA, net result as of September 30). This content aligns perfectly with the definition of an Interim / Quarterly Report (IR), which covers a period shorter than a year. Although it is presented as a press release via DGAP, the core content is the comprehensive financial reporting for the nine-month period, making 'IR' the most accurate classification over a simple 'ER' (Earnings Release, which is usually just highlights) or 'RPA' (Report Publication Announcement, which would only announce the report's availability). 9M 2020
2020-11-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.